AGC Biologics Appoints Alberto Santagostino as New CEO
AGC Biologics appoints Alberto Santagostino as the new CEO, signaling a new chapter for the company and its commitment to delivering reliable and expert services to the biopharmaceutical industry.
This news matters as it signals a new chapter for AGC Biologics and its commitment to delivering reliable and expert services to the biopharmaceutical industry. Alberto's appointment is expected to enhance the company's reputation and solidify its position as a top CDMO service provider, impacting the industry as a whole.